CQP(SZ:000950) Xin Lang Cai Jing·2025-11-11 03:03Core Viewpoint - The stock of Chongqing Zhongyao Holdings has shown a positive trend with a year-to-date increase of 5.79% and a recent rise of 4.81% over the last five trading days, indicating a strong performance in the pharmaceutical distribution sector [1][2]. Financial Performance - For the period from January to September 2025, Chongqing Zhongyao Holdings reported a revenue of 62.211 billion yuan, reflecting a year-on-year growth of 4.22%. The net profit attributable to shareholders was 384 million yuan, marking a significant increase of 31.41% compared to the previous year [2]. - The company has distributed a total of 864 million yuan in dividends since its A-share listing, with 294 million yuan distributed over the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Chongqing Zhongyao Holdings was 42,000, a decrease of 4.05% from the previous period. The average number of circulating shares per shareholder increased by 4.22% to 41,112 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 10.091 million shares, an increase of 851,000 shares from the previous period, while the Southern CSI 1000 ETF reduced its holdings by 55,600 shares to 7.898 million shares [3]. Stock Market Activity - On November 11, the stock price of Chongqing Zhongyao Holdings rose by 2.17% to 5.66 yuan per share, with a trading volume of 59.4435 million yuan and a turnover rate of 0.62%. The total market capitalization reached 9.782 billion yuan [1]. - The net outflow of main funds was 4.8241 million yuan, with large orders showing a buy of 7.9016 million yuan and a sell of 12.8199 million yuan, indicating mixed investor sentiment [1].